Share on LinkedInShare on LinkedIn

ARTICLE · 05 JANUARY 2023

Restrictions On Advertising Rules For Medicinal Products

The case dates back to March 2016, when EUROAPTIEKA, a Latvian company operating in the field of medicinal products, carried out an advertising campaign...

PortugalMedia, Telecoms, IT, Entertainment

The Court of Justice of the European Union (CJEU) issued a decision in the EUROAPTIEKA case on 22 December 2022. In the decision, the CJEU concluded that a national provision prohibiting the advertising of medicinal products on the basis of price (by announcing a promotion or a package sale with other medicines or products) is compatible with EU law, even when that advertising does not mention a particular medicine. According to the CJEU, price-based promotional campaigns do not encourage the rational use of the medicine, so they should be prohibited by Member States.

The case dates back to March 2016, when EUROAPTIEKA, a Latvian company operating in the field of medicinal products, carried out an advertising campaign in which it advertised a price reduction on the purchase of any medicine when customers purchased at least three products. That advertising campaign was prohibited by the Latvian Public Health Inspectorate. The decision was based on a national

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from